XML 22 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1Close
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income (loss) $ 782 $ 1,097
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Interest credited to policyholders’ account balances 1,171 964
Policy charges and fee income (1,231) (1,182)
Net derivative (gains) losses 1,584 1,758
Credit and intent to sell losses on available for sale debt securities and loans 35 80
Investment (gains) losses, net 20 63
(Gains) losses on businesses held-for-sale (135) 2
Realized and unrealized (gains) losses on trading securities (43) (44)
Non-cash long term incentive compensation expense 53 41
Amortization and depreciation 429 380
Remeasurement of liability for future policy benefits (7) (3)
Change in market risk benefits (1,233) (955)
Equity (income) loss from limited partnerships (58) (61)
Changes in:    
Net broker-dealer and customer related receivables/payables (168) (686)
Reinsurance recoverable (626) (801)
Segregated cash and securities, net 276 643
Capitalization of deferred policy acquisition costs (561) (450)
Future policy benefits 275 40
Current and deferred income taxes 155 (1,177)
Other, net 205 65
Net cash provided by (used in) operating activities 923 (226) Close
Proceeds from the sale/maturity/pre-payment of:    
Fixed maturities, available-for-sale 5,284 4,790
Fixed maturities, at fair value using the fair value option 399 239
Mortgage loans on real estate 460 236
Trading account securities 512 480
Short term investments 571 2,402
Other 331 463
Payment for the purchase/origination of:    
Fixed maturities, available-for-sale (10,523) (5,878)
Fixed maturities, at fair value using the fair value option (426) (309)
Mortgage loans on real estate (1,148) (1,114)
Trading account securities (1,446) (660)
Short term investments (384) (2,218)
Other (473) (388)
Cash settlements related to derivative instruments, net (1,438) (655)
Investment in capitalized software, leasehold improvements and EDP equipment (99) (57)
Other, net 453 152
Net cash provided by (used in) investing activities (7,927) (2,517) Close
Policyholders’ account balances:    
Deposits 9,033 9,060
Withdrawals (4,719) (4,830)
Transfers (to) from Separate Accounts 832 647
Payments of market risk benefits (376) (375)
Repayment of short-term financings (254) (759)
Change in collateralized pledged assets (75) (45)
Change in collateralized pledged liabilities 4,829 2,282
Issuance of long-term debt 0 496
Repayment of long term debt (565) 0
Proceeds from collateralized loan obligations 0 40
Proceeds from notes issued by consolidated VIEs 176 362
Dividends paid on common stock (151) (150)
Dividends paid on preferred stock (40) (40)
Purchase of AB Holding Units to fund long-term incentive compensation plan awards, net (34) (19)
Purchase of treasury shares (500) (440)
Purchases (redemptions) of noncontrolling interests of consolidated company-sponsored investment funds 291 63
Distribution to noncontrolling interest of consolidated subsidiaries (189) (174)
Change in securities lending 36 29
Other, net 15 (4)
Net cash provided by (used in) financing activities 8,309 6,143 Close
Effect of exchange rate changes on cash and cash equivalents (13) 16 Close
Change in cash and cash equivalents 1,292 3,416 Close
Cash and cash equivalents, beginning of period 8,239 4,281
Change in cash of businesses held-for-sale 153 (4)
Cash and cash equivalents, end of period 9,684 7,693
Non-cash transactions from investing and financing activities:    
Securities received in exchange for the 2029 Notes [1] 540 0
Right-of-use assets obtained in exchange for lease obligations $ 222 $ 31
[1] See Note 16 of the Notes to these Consolidated Financial Statements for details of the the 2029 Trust Eligible Assets received in exchange for the 2029 Notes.